Visiting the first "Longevity Medicine" factory in China: the products have been certified by the US FDA and sold to many countries.

Recently, the100t coenzyme factory invested by the online celebrity anti-aging brand Gene Harbor in Zhejiang was officially put into production. Its founder and CEO Alvin Wong led us to unveil the mystery of the world's first "Longevity Medicine" factory for the first time at the opening ceremony.

Following in the footsteps of Alvin Wong and the person in charge of the factory, dozens of media were able to go into the factory to find out. Just entering the door, a serious breath of "experimental land" lingered. Dozens of reactors about 5 meters high and hundreds of metal pipes are self-contained and are working quietly. Alvin Wong said that in these humble metal cans, a biological enzyme evolution process that can be completed in millions or even millions of years in nature is taking place.

In his early years, he studied under the microbiologist Jiao and studied for graduate students majoring in microbial metabolism. Later, he studied for a Ph.D. in molecular biology at the University of Wisconsin, USA, and became teachers, students and friends with Professor Howard Temin and Professor oliver smithies, the Nobel Prize winners in physiology. Over the past 40 years, Alvin Wong has devoted itself to the research in the field of biocatalysis, and Gene Harbor has become the first and only company in the world with a complete enzyme preparation industry chain and leading technology in the main steps of the industry chain. He told reporters that there are seven main steps in enzyme production technology, six of which are ahead of the world. It will take at least ten years for others to surpass them.

In recent years, SyntheticBiology has become popular. It uses engineering ideas and methods and combines biotechnology to redesign microorganisms, reduce costs and produce new products. The breakthrough in the application of biological enzyme transformation has broadened the road of human health and longevity, making anti-aging products no longer the exclusive luxury of the rich.

Before the factory on the south bank of Hangzhou Bay was put into production, 20 17 years ago, they had mass-produced the anti-aging substance β-nicotinamide mononucleotide discovered by Harvard University by full enzyme method, which reduced its price to one tenth of the market price at that time and improved its purity to 99.9%. But the world knows very little. Alvin Wong described it this way: "Two years ago, at most 1 1,000 people in China knew about β -nicotinamide mononucleotide, of which 1 1,000 people were their own employees".

The enzyme technology of "turning stone into gold" makes high technology fly into the homes of ordinary people. In 2065438+2008, when the domestic market paid attention to β -nicotinamide mononucleotide and its precursor products, JD.COM invited Ai Yinmu to settle in. On the well-known reagent website, one gram of nicotinamide mononucleotide costs 20 thousand yuan, and it is often out of stock. The arrival of Alvin Wong and its low-priced products soon set off a wave of buying, and it was out of stock for three times.

On the track of more than 4,000 kinds of nutritional products, it has maintained the top ten brand growth rate, and its sales have increased by more than 30 times in more than one year. One of the important goals of Yuyao factory is to alleviate the shortage of domestic demand. At the commissioning ceremony, Alvin Wong said that the annual production capacity can be doubled to 200 tons/year, and 800,000 middle-aged and elderly people can benefit from the improvement of production efficiency by about 20% and the reduction of cost by about 40%. However, judging from the growth trend of the elderly population in the next few decades, factories with a total area of nearly 40,000 square meters with an investment of nearly 654.38+0 billion before and after may be far from the market demand.

According to the China Development Report 2020: Trends and Policies of Population Aging in China, in 2020, the elderly population over 65 years old in China will be about 65.438+0.8 billion, accounting for 654.38+0.3% of the total population, and the population over 60 years old will be close to 500 million in 2050. The ability to meet the needs of 800,000 people is just a drop in the ocean. Alvin Wong told reporters that at this stage, only "Xiao He showed his sharp corner".

American economist Paul? Pilzer once called the big health industry the global "wealth The 5th Wave" after the IT industry; Ma Yun also predicted: "The next person to surpass him must be in the field of big health. By the end of 20 18, the life expectancy of China's population reached 77 years, but the healthy life expectancy was only 68.7 years. Among the 249 million elderly people, more than 65.438+0.8 billion people suffer from diseases of 65.438+0 or above, and residents have eight years to live with diseases.

Wang Haidong, director of the Department of Aging Health of the Health and Health Commission, said that we have made achievements in "living long", but there is still a gap in "living healthy". Improving healthy life will become an important goal of health care in the next stage. Anti-aging products represented by coenzyme may become an important way out.

After World War II, the development of modern medicine such as antibiotics, vaccines and public health has more than doubled the life span of human beings and completed the transition from 40 to 80 years old. Alvin Wong said that the next leap in human life span is likely to come from coenzyme products. This kind of products can prevent and slow down the aging process and help to improve healthy life.

At the commissioning ceremony, Alvin Wong said that after the first-phase100t plant was successfully put into operation, it would invest 654.38+000 billion yuan to build the second-phase coenzyme plant with an annual output of 5000-6543.8+00000 tons in the next five years, and push its products to the world. Now we have GRAS certification and GMP certification from FDA, which has opened the American and Japanese markets and will go to more regions in the future.

For a long time, the length of life was controlled by heaven. In this era, the extension of human life seems to have become an ongoing fact. Bank of America Merrill Lynch, a world investment bank, believes that with the development of anti-aging technology companies, human life expectancy may soon exceed 100 years. Gene Port will be listed on the Hong Kong Stock Exchange as early as April or May next year, so as to go global and win more capital support.